Codie Sanchez, managing director at private equity investment firm Cresco Capital Partners, shared her criticism in a recent interview with the Investing News Network (INN) about the over estimation done for the public cannabis market as a private investor of the space.

Sanchez told INN there’s been a wide margin of volatility coming from the public markets when it comes to the estimations of value for cannabis companies. Sanchez was a featured speaker at the MJBizConINT’L event in Toronto.

“The public (market valuations are) nuts,” Sanchez told INN. “Why would I invest in somebody that’s trading at a valuation or multiple that is almost impossible for them to hit?”


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

As a private investor, Sanchez said the volatility seen in the public markets has created a variety of reactions to the private side of the industry.

“We haven’t necessarily seen very many down rounds or haircuts on the total amount that they can go and raise at but we certainly have seen companies have a harder time raising, which is good for us as investors and a pullback on some of the more ridiculous valuations we saw on the market,” Sanchez said.

The executive joined Cresco Capital Partners earlier this year. In June, the firm raised US$60 million in its oversubscribed cannabis private equity fund, the second fund for cannabis investment.

Matthew Hawkins, managing principal of the firm said, they are now planning a third cannabis fund with the goal to raise US$200 million. “This fund will continue to target investments in value-add opportunities in the legalized cannabis space both plant touching and non-plant touching,” he said.

Watch the interview above for more on what Sanchez had to say.

Don’t forget to look for the rest of our coverage of MJBizConINT’L, with exclusive interviews and more insights from the show. You can also follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less